Pay in 4 interest-free payments of $83.25 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
Pre-clinically LY-2090314 i stabilizes β-catenin and enhances the efficacy of platinum based regimens
Hydroxy Iloperidone
InChi: InChI=1S/C20H27N5O2/c26-20-12-9-15-14-17(10-11-18(15)21-20)27-13-5-4-8-19-22-23-24-25(19)16-6-2-1-3-7-16/h10-11
H-PGDS Inhibitor I
InChi: InChI=1S/C25H20N4O2S2/c30-22(28-21-12-11-18(15-26-21)17-7-3-1-4-8-17)16-33-25-27-20-13-14-32-23(20)24(31)29(25)19-9-5-2-6-10-19/h1-12
L-Phenylalanine NE-781 Pre-clinically LY-2090314 i stabilizes β-cateninASTX 029 is an orally bioavailable inhibitor of the extracellular signal regulated kinases (ERK) 1 and 2, with potential antineoplastic activity. ASTX 029 inhibits ERK dependent tumor cell proliferation and survival. Product information CAS Number: 63 91 2 Molecular Weight: 165. 19 Formula: C9H11NO2 Chemical Name: (2S) 2 amino 3 phenylpropanoic acid Smiles: N[C@@H](CC1C=CC=CC=1)C(O)=O InChiKey: COLNVLDHVKWLRT QMMMGPOBSA N InChi: InChI=1S C9H11NO2 c10
US$ 24.99
US$ 32.00
US$ 146.61
US$ 18.00
US$ 34.00
US$ 24.00